Diabetes
Conditions
Interventions
A/B/C:Continuously wear the study medical device for 15 days
Sponsors
The First Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged > 18 years; 2. Diagnosis of diabetes mellitus; 3. Willing to continuously wear the study medical device for 15 days and allow medical personnel to take blood flow samples per the study protocol; 4. Voluntarily participating and signing a written informed consent before enrollment.
Exclusion criteria
Exclusion criteria: 1. Subject has MRI appointment scheduled during the period of study participation; 2. There are diffuse subcutaneous nodules on the arm; 3. Acute complications of diabetes; 4. Patients with coagulation disorders, the criteria to determine coagulation disorders are: (1) Activated partial prothrombin time (APTT) is exceeding the 1.5 times of the upper limit of normal range, or exceeding the lower limit of normal range; or (2) Prothrombin time (PT) is exceeding the 1.5 times of the upper limit of normal range, or exceeding the lower limit of normal range; 5. Subject has participated any other clinical trial(s) within the last one month; 6. Subjects that the investigator determined as not suitable to join this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy; | — |
Countries
China
Contacts
Public ContactMu Yiming
Chinese PLA General Hospital
Outcome results
None listed